Systematic Review and Meta-analysis of Pharmacist-Led Transitions of Care Services on the 30-Day All-Cause Readmission Rate of Patients with Congestive Heart Failure Connor McKayChanhyun ParkSean Hyungwoo Kim Systematic Review 17 May 2019 Pages: 703 - 712
Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review Chiara RapinesiGeorgios D. KotzalidisPaolo Girardi Systematic Review 31 May 2019 Pages: 713 - 735
Appropriate Timing of Discontinuation of Tacrolimus Therapy for Refractory Ulcerative Colitis Satohiro MatsumotoHaruka OtakeHirosato Mashima Original Research Article 07 May 2019 Pages: 737 - 744
Lilly Insulin Glargine Versus Lantus® in Type 2 Diabetes Mellitus Patients: India and East Asia Subpopulation Analyses of the ELEMENT 5 Study Viswanathan MohanKyu Jeung AhnErik Spaepen Original Research Article Open access 22 May 2019 Pages: 745 - 756
Emerging Trends in Metformin Prescribing in the United States from 2000 to 2015 Samantha LeGrace C. Lee Original Research Article 23 May 2019 Pages: 757 - 763
Development Strategy and Relative Bioavailability of a Pediatric Tablet Formulation of Ticagrelor Mohammad NiaziJenny WissmarPer Johanson Original Research Article 28 May 2019 Pages: 765 - 773
Assessing the Value of Time Series Real-World and Clinical Trial Data vs. Baseline-Only Data in Predicting Responses to Pregabalin Therapy for Patients with Painful Diabetic Peripheral Neuropathy Joe Alexander JrRoger A. EdwardsBruce Parsons Original Research Article 26 June 2019 Pages: 775 - 786
Pharmacokinetics of Imipenem in Critically Ill Patients with Life-threatening Severe Infections During Support with Extracorporeal Membrane Oxygenation Sutep JaruratanasirikulVeerapong VattanavanitSomchai Sriwiriyajan Short Communication 23 May 2019 Pages: 787 - 798
Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response? Walter FriesAlessandra BelvedereGianluca Trifirò Short Communication 06 June 2019 Pages: 799 - 803
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features Katherine A. Lyseng-Williamson Adis Disease Management Open access 18 July 2019 Pages: 805 - 819
Comment on: “Drugs That Can Kill a Toddler with One Tablet or Teaspoonful: A 2018 Updated List” Michael E. MullinsSteven J. Fishburn Letter to the Editor 15 June 2019 Pages: 821 - 822
Response to: “Comment on: Drugs that Can Kill a Toddler with One Tablet or Teaspoonful: A 2018 Updated List” Gideon Koren Letter to the Editor 26 June 2019 Pages: 823 - 824